The Proof with Simon Hill cover image

Preventing and treating cardiovascular disease (Lipid Series - Part 3) | Dr Thomas Dayspring

The Proof with Simon Hill

00:00

The Benefits of a PCS Canine Inhibitor

A new drug called inclycerin is the generic name nclis rn it goes right into the liver and by acting on rna you block transcription. It's not approved no outcome data in lp little a patient but it is being used i can tell you that the last thing is there's a new pcs canine  it had the first two were monoclonal antibodies so pcs canine has produced the antibody binds to it and it kills the little enzyme here can't work. The newer drug is an sirin a silencing rna drug and it's selectively delivered only to the liver through gall neck which is a hepatic specific carrier.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app